Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.

@article{Radhakrishnan2010MycophenolateMA,
  title={Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.},
  author={Jai Radhakrishnan and Dimitrios Anestis Moutzouris and Ellen M. Ginzler and Neil Solomons and Ilias I. Siempos and Gerald B. Appel},
  journal={Kidney international},
  year={2010},
  volume={77 2},
  pages={152-60}
}
Class V lupus nephritis (LN) occurs in one-fifth of biopsy-proven cases of systemic lupus erythematosus. To study the effectiveness of treatments in this group of patients, we pooled analysis of two large randomized controlled multicenter trials of patients with diverse ethnic and racial background who had pure class V disease. These patients received mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC) as induction therapy for 24 weeks, with percentage change in proteinuria and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 67 extracted citations

Understanding lupus nephritis: diagnosis, management, and treatment options

International journal of women's health • 2012
View 5 Excerpts
Highly Influenced

Studies on Lupus Nephritis

View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…